{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:18:22Z","timestamp":1770520702491,"version":"3.49.0"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Objectives: The present study aimed to explore psychiatrists\u2019 perceptions of duloxetine in routine clinical practice, focusing on its efficacy, tolerability, and treatment adherence in major depressive disorder (MDD) and generalized anxiety disorder (GAD). Methods: A structured questionnaire was administered to 97 psychiatrists from different regions of Spain. The survey covered demographic and professional data, prescription frequency, perceived clinical efficacy, tolerability, dosing patterns, and factors influencing adherence. Results: Overall, duloxetine was perceived as an effective treatment for both MDD and GAD, particularly in patients with somatic symptoms or comorbid anxiety. Tolerability was also positively rated, with nausea and fatigue identified as the adverse effects most commonly associated with reduced adherence. In addition, patient education and close follow-up were identified as the most effective strategies to improve adherence, whereas digital tools were considered promising but underused. Compared with other antidepressants, duloxetine was viewed as having a favorable balance between efficacy and tolerability, with similar or slightly higher adherence rates. Conclusions: These findings reflect a positive clinical appraisal of duloxetine among psychiatrists, highlighting its role as a versatile therapeutic option for affective and anxiety disorders, within the context of routine clinical practice in Spain, provided that appropriate adherence-support strategies are implemented.<\/jats:p>","DOI":"10.3390\/brainsci16020157","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:08:17Z","timestamp":1769702897000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Adherence to Duloxetine in Psychiatric Practice: A Cross-Sectional Evaluation of Clinicians\u2019 Experience"],"prefix":"10.3390","volume":"16","author":[{"given":"Cielo","family":"Garc\u00eda-Montero","sequence":"first","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), University of Alcal\u00e1, 28801 Alcala de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-6397","authenticated-orcid":false,"given":"\u00d3scar","family":"Fraile-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), University of Alcal\u00e1, 28801 Alcala de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Chart-Pascual","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Osakidetza Basque Health Service, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain"},{"name":"Bioaraba Research Institute, 01009 Vitoria-Gasteiz, Spain"},{"name":"University of the Basque Country UPV\/EHU, 01006 Vitoria-Gasteiz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-2189","authenticated-orcid":false,"given":"Luis","family":"Guti\u00e9rrez-Rojas","sequence":"additional","affiliation":[{"name":"Psychiatry Service, Hospital Universitario San Cecilio, 18016 Granada, Spain"},{"name":"Department of Psychiatry and CTS-549 Research Group, Institute of Neurosciences, University of Granada, 18071 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Alvarez-Mon","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), University of Alcal\u00e1, 28801 Alcala de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n en Red de Salud Mental (CIBERSAM), 28029 Madrid, Spain"},{"name":"Department of Psychiatry and Mental Health, University Hospital Infanta Leonor, 28031 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-7510","authenticated-orcid":false,"given":"Melchor","family":"Alvarez-Mon","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), University of Alcal\u00e1, 28801 Alcala de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"},{"name":"Immune System Diseases-Rheumatology and Internal Medicine Service, University Hospital Pr\u00edncipe de Asturias, 28805 Alcala de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-1708","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Ortega","sequence":"additional","affiliation":[{"name":"Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD), University of Alcal\u00e1, 28801 Alcala de Henares, Spain"},{"name":"Ram\u00f3n y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"ref_1","unstructured":"Dhaliwal, J.S., Spurling, B.C., and Molla, M. (2023). Duloxetine. StatPearls, StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1533-2500.2012.00578.x","article-title":"A Review of Duloxetine 60 mg Once-Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain","volume":"13","author":"Pergolizzi","year":"2013","journal-title":"Pain Pract."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, C., Ni, K., Qi, M., Li, J., Yang, K., and Luo, Y. (2022). The Anterior Cingulate Cortex Contributes to the Analgesic Rather than the Anxiolytic Effects of Duloxetine in Chronic Pain-Induced Anxiety. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.992130"},{"key":"ref_4","first-page":"833","article-title":"Review of Duloxetine in the Management of Diabetic Peripheral Neuropathic Pain","volume":"3","author":"Smith","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13018-023-03995-z","article-title":"Duloxetine for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis","volume":"18","author":"Migliorini","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/14737175.8.4.527","article-title":"Duloxetine in the Treatment of Major Psychiatric and Neuropathic Disorders","volume":"8","author":"Schennach","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rodrigues-Amorim, D., Olivares, J.M., Spuch, C., and Rivera-Baltan\u00e1s, T. (2020). A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.554899"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, X., Zhu, L., Zhou, C., Liu, J., Du, H., Wang, C., and Fang, S. (2018). Efficacy and Tolerability of Short-Term Duloxetine Treatment in Adults with Generalized Anxiety Disorder: A Meta-Analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194501"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/1516-4446-2020-0935","article-title":"How Can We Improve Antidepressant Adherence in the Management of Depression? A Targeted Review and 10 Clinical Recommendations","volume":"43","author":"Solmi","year":"2021","journal-title":"Rev. Bras. Psiquiatr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez de Le\u00f3n, B., Abt-Sacks, A., Acosta Artiles, F.J., Del Pino-Sede\u00f1o, T., Ramos-Garc\u00eda, V., Rodr\u00edguez \u00c1lvarez, C., Bejarano-Quisoboni, D., and Trujillo-Mart\u00edn, M.M. (2022). Barriers and Facilitating Factors of Adherence to Antidepressant Treatments: An Exploratory Qualitative Study with Patients and Psychiatrists. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192416788"},{"key":"ref_11","first-page":"223","article-title":"Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder","volume":"27","author":"Ta","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","article-title":"Clinical and Economic Impact of Non-Adherence to Antidepressants in Major Depressive Disorder: A Systematic Review","volume":"193","author":"Ho","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4102\/sajpsychiatry.v31i0.2345","article-title":"Medication Non-Adherence in Re-Admitted Patients at a Psychiatry Hospital: A Qualitative Study","volume":"31","author":"Zwide","year":"2025","journal-title":"S. Afr. J. Psychiatr."},{"key":"ref_14","first-page":"89","article-title":"Treatment Discontinuation and Tolerability as a Function of Dose and Titration of Duloxetine in the Treatment of Major Depressive Disorder","volume":"12","author":"Harada","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Del Pino-Sede\u00f1o, T., Gonz\u00e1lez-Pacheco, H., Gonz\u00e1lez de Le\u00f3n, B., Serrano-P\u00e9rez, P., Acosta Artiles, F.J., Valcarcel-Nazco, C., Hurtado-Navarro, I., Rodr\u00edguez \u00c1lvarez, C., Trujillo-Mart\u00edn, M.M., and MAPDep Team (2024). Effectiveness of Interventions to Improve Adherence to Antidepressant Medication in Patients with Depressive Disorders: A Cluster Randomized Controlled Trial. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1320159"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2025.08.003","article-title":"Efficacy of Pharmacogenetic (PGx)-Guided Antidepressant Treatment on Functional Outcomes and Quality of Life in Adults with Anxiety and Affective Disorders: A Systematic Review and Meta-Analysis","volume":"100","author":"Budde","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alvarez-Mon, M.A., Garc\u00eda-Montero, C., Fraile-Martinez, O., Quintero, J., Fernandez-Rojo, S., Mora, F., Guti\u00e9rrez-Rojas, L., Molina-Ruiz, R.M., Lahera, G., and \u00c1lvarez-Mon, M. (2023). Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists. Brain Sci., 13.","DOI":"10.3390\/brainsci13020333"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fraile-Martinez, O., Garcia-Montero, C., Alvarez-Mon, M.A., Ortega, M.A., Alvarez-Mon, M., and Quintero, J. (2025). Delving into the Perception, Use, and Context of Duloxetine in Clinical Practice: An Analysis Based on the Experience of Healthcare Professionals. Brain Sci., 15.","DOI":"10.3390\/brainsci15070757"},{"key":"ref_19","first-page":"271","article-title":"Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study","volume":"9","author":"Wohlreich","year":"2007","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4306\/pi.2012.9.4.391","article-title":"The Effect of Initial Duloxetine Dosing Strategy on Nausea in Korean Patients with Major Depressive Disorder","volume":"9","author":"Lee","year":"2012","journal-title":"Psychiatry Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21501319241286313","DOI":"10.1177\/21501319241286313","article-title":"Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study","volume":"15","author":"Meng","year":"2024","journal-title":"J. Prim. Care Community Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/PPA.S27436","article-title":"Impact of Pharmacist Interventions on Patients\u2019 Adherence to Antidepressants and Patient-Reported Outcomes: A Systematic Review","volume":"6","author":"Qureshi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7812\/TPP\/24.117","article-title":"Comparing In-Person, Telephonic, and Video-Based Treatment of Depression in Adult Primary Care During the COVID-19 Pandemic","volume":"29","author":"Metrikin","year":"2025","journal-title":"Perm. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez de Le\u00f3n, B., del Pino-Sede\u00f1o, T., Serrano-P\u00e9rez, P., \u00c1lvarez, C.R., Bejarano-Quisoboni, D., and Trujillo-Mart\u00edn, M.M. (2022). Effectiveness of Interventions to Improve Medication Adherence in Adults with Depressive Disorders: A Meta-Analysis. BMC Psychiatry, 22.","DOI":"10.1186\/s12888-022-04120-w"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/2\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:12:02Z","timestamp":1770441122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/2\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["brainsci16020157"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16020157","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}